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Summary: The extracellular matrix of normal liver contains several types of proteoglycans including heparan
sulphate, chondroitin sulphate isomers, dermatan sulphate, and the glycosaminoglycan, hyaluronic acid. In
the present study both the synthesis and secretion äs well äs the pattern of radioactively labeled proteoglycans
and hyaluronic acid of hepatocytes, fat-storing cells (Ito cells), and Kupffer cells maintained in monolayer
cultures under mostly identical conditions were compared to assess their relative contribution to hepatic
proteoglycan synthesis. Fat-storing cells were identified äs the main type of cell producing and secreting
proteoglycan and hyaluronic acid. More than 70% of labeled proteoglycan and hyaluronic acid were secreted
into the medium. Heparan sulphate is the main type of proteoglycan in hepatocytes, whereas in the medium
of fat-storing cells, chondroitin sulphate and dermatan sulphate comprise the mäjor fractions. Hyaluronic
acid was not detectable in hepatocyte cultures and found only in low amounts in the medium of Kupffer cells.
The results point to a stringent quantitative and qualitative cellular compartmentation of proteoglycan
synthesis in liver with fat-storing cells äs the most important cell type for matrix proteoglycan and hyaluronic
acid production.
Introduction
The main components of the extracellular matrix of
human and animal liver are several types of collagens
(I, III, IV, V, VI), some structüral glycoproteins (fi-
bronectin, laminin), a group of proteoglycans (pro-
teoheparan sulphate, proteochondroitin sulphate,
proteodermatan sulphate), and hyaluronic acid
(l —4). The cellular sources of the matrix molecules
have been identified only partially. Whereas the for-
mation of specific types of collagens (5 — 18), fibro-
nectin (19 — 21), and of the basement membrane gly-
cpprotein laminin (22) has been demonstrated by im-
munocytochemical and cell culture techniques in par-
enchymal (5 — 14) and non-parenchymal (15—22)
cells, müch less is kiiown about the cell-type-specific
fonnation of proteoglycans and hyaluronate. Re-
cently, we demonstrated the ability of cultured fat
storing cells to'produce suiphated proteoglycans (23)
and hyaluronate (24). Neither glycosaminoglycan syn-
thesis nor secretion in cultures of parenchymal and
other non-parenchymal cells were evaluated under
comparable conditions. Information on the relative
contribution of the various cell types to hepatic pro-
teoglycan and hyaluronate synthesis will be important
since under pathological conditions like liver fibrosis
(25—28) and hepatocellular carcinoma (29, 30), both
the total glycosaminoglycan content and the pattern
of suiphated and non-sulphated glycosaminoglycans
chanige greatly. In the present study we attempted to
compare the synthesis, secretion, and molecular pro-
file of glycosaminoglycans of hepatocytes, fat-storing
cellSj and Kupffer cells kept in culture under largely
identical conditions. The results indicate that the fat
storing cell, a sinusoidal type of non-parenchymal
liver cell engaged primarily in the storage and metab-
olism of retinoids (31, 32), is the most important cell
type in hepatic proteoglycan and hyaluronate synthe-
sis.
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Materials and Methods
Isolat ion and cu l tu re of hepatocytes, fat-s toring
cells, and Kupffer cells
All cells were prepared from male Sprague Dawley rats (Lip-
pische Versuchstierzucht, Extertal, FRG) receiving a Standard
lab chow diet (type Han MR5 containing 15 kU vitamin A per
kg) and water ad libitum.
Hepatocytes were isolated from rats (250-320 g body weight,
fasted overnight) by the method of Seglen (33) incorporating
slight modifications (34). The rats were anaesthetized with an
intraperitoneal injection of phenobarbital (Nembutal®, 54 mg/
kg body weight) and the liver was preperfused in situ via the
portal vein in a non-circulating way for 10 min with Ca2+-free
Hank's balanced salt solution, pH 7.4 at 37 °C, at a flow rate
of 0.03 l/min, followed by recirculating perfusion ex situ for a
further 15 min with Ca2+ (5 mmol/1), collagenase (0.5 g/l, Clos-
tridium histolyticum, type I, Sigma Chem. Co., Munich, FRG)
and deoxyribonuclease (0.05 g/l, bovine pancreas, type I, Boeh-
ringer GmbH, Mannheim, FRG) containing oxygenated Hank's
balanced salt soltuion, pH 7.4 at 37 °C, at a flow rate of 0.05
l/min. Thereafter, the liver capsule was gently removed, the
tissue was dissected and incubated in 100 ml collagenase-con-
taining oxygenated Hantes buffer for 10 min at 37 °C under
constant swirling, after which the material was filtered through
double layer of sterile gauze. The initial cell Suspension obtained
in the filtrate was purified by differential centrifugation, first
for 2 min at 36 g, then twice for 2 min at 17 g, all at 4 °C. The
viability of the Tmal parenchymal cell Suspension, checked by
trypan blue exclusion (2.5 g/l), was between 80 and 90%, the
cell recovery was between 2· l O8 and 5· l O8 cells/liver, and the
contamination with non-parenchymal cells was less than 1%.
Cells were seeded at a density of 0.12 · 106 cells/cm2 in 6-well
plates (diameter 35 mm, Greiner GmbH, Nürtingen, FRG) and
cultured in 5 ml Ham's F12 medium (Boehringer GmbH,
Mannheim, FRG) supplemented with 4 mmol/1 L-ghitamine,
fetal calf serum, vohime fraction 0.1 (Boehringer GmbH), pen-
icillin (100 kU/1), streptomycin (100 mg/1), and 20 U/l insulin
(bovine pancreas, Sigma Chem. Co., FRG). The first change
of medium was 3 h after plating, during which non-adherent
and dead cells were removed. Thereafter, the medium was
changed daily. Cells were kept at 37 °C in a humidified atmos-
phere of 0.05 CO2 and 0.95 air.
Fat-storing cells (perisinusoidal lipocyles) were prepared from
l year old rats (body weight 500 —700g). Nonparenchymal
liver cells were isolated by the pronase-collagenase method of
de Leeuw et al. (35) in a sequence of non- and recirculating
perfusions incorporating some minor modifications described
in detail elsewhere (23). Fat-storing cells were purified from the
non-parenchyraal liver cell Suspension by single-step density
gradient centrifugation with Nycodenz^ (analytical grade, Nye-
gaard and Co. AS, Oslo, Norway), exactly äs described previ-
ously (23). The purity of freshly isolated cells used in this study
was at least 90%, cell viability checked by trypan blue exclusion
was more than 80%, and the yield ranges from 5 · l O6 to 60 · l O6
cells per liver. After the first change of medium most of the
contaminating cells were removed, and the monolayers were
essentially free of impurities. Fat-storing cells were identified
by their typical light microscopic appearance, transmission elec-
tron microscopy (23), positive immunofluorescence staining for
desmin (36), and vitamin A-specific autofluorescence at an
excitation wavelength of 328 nm (23). The cells were seeded at
an initial density between 0.25 and 0.40 · 166/2cm2 and main-
tained äs monolayers in 24-well culture plates (Falcon®, Becton
& Dickinson, Oxnard, USA) in l ml/2 cm2 well of Dulbecco's
modification of Eagles medium (Flow Laboratories GmbH,
Bonn, FRG) containing 4 mmol/1 L-glutamine, penicillin (100
kU/1), streptomycin (100 mg/1) and fetal calf serum, volume
fraction 0.1 (Boehringer GmbH) in a humidified atmosphere
of 0.05 CO2 and 0.95 air. The first change of medium was made
about 20 h after seeding, the subsequent changes were made
daily.
Kupffer cells were isolated either simultaneously with or (more
frequently) separately from fat-storing cells. The sinusoidal cell
Suspension was prepared and purified with a single-step Ny-
codenz® gradient äs described above. The cell Sediment ob-
tained after Nycodenz^ gradient centrifugalion was resüs-
pended in Gey's balanced salt solution and washed by centri-
fugation (450 g, 7 min, 4 °C). The Sediment was gently sus-
pended in Gey's solution supplemented with 3 g/l bovine serum
albumin and subjected to centrifugal elutriation at 4 °C for
purification of Kupffer cells in a JE-6JB type rotor equipped
with a Standard Separation chamber, using a Beckman model
J-6B centrifuge. Details of the procedure have been described
previously (37). Kupffer cells recovered from elutriation were
collected by centrifugation for 7 min at 450 g and 4 °C and
resuspended in the same culture medium described above for
fat-storing cells. The cells were seeded at a density between 0,25
and 0.40 · l O6 cells/2 cm2 in 24rwell plates and incubated in l ml
of Dulbecco-medium (described above). The viability äs checked
by trypan blue exclusion was greater than 90%. Identification
and assessment of the purity of the Kupffer cells were performed
by light- and electron microscopy (38), peroxidase staining, by
phagocytosis of latex beads (LB 11 polystyrene beads, mean
diameter 1.1 ; Sigma Chem. Co., St. Louis, USA) for 60
min at 37 °C (23), and by demonstration of positive immuno-
fluorescence staining for vimentin and negative staining for
desmin (39). Aecording to these criteria the purity of seeded
Kupffer cells was greater than 95%. The first medium change
was made 12h after seeding, the subsequent changes were
performed every 24 h.
Determination of the synthesis of total and specific
types of glycosaminoglycans
The synthesis of sulphäted glycosaminoglycans was determined
by the incorporation of either [35S]sulphate (18.5-22.2 GBq/
mmol; 740 MBq/1 medium; New England Nuclear Corp., Bös-
ton, USA) or D-[6-3H]glucosamine hydrochloride (1.48 TBq/
mmol; 740 MBq/1 medium, Arnersham Buchler GmbH, Braun-
schweig, FRG) during a labeling period of 24 h. The addition
of isotopes (usually on the 3rd day of primary culture) was
preceded by a change of medium. In hepatocyte cultures, Ham's
F12 medium was replaced by supplemented Dulbecco's modi-
fication of Eagles medium withoüt insulin; the hepatocyte me-
dium during labelling was therefore identical to that of the fat-
storing cells and Kupffer cells. Labeled glycosaminoglycans were
measured separately in the medium and cell-layer of the cul-
tures. After taking off the medium the cell layer was rinsed
three times with phosphate-buffered saline. The cells were de-
tached from the well by three cycles of freezing (with liquid
nitrogen) and thawing and rinsed out with water. Alternatively,
cells were detached by trypsinization (5min at 37 °C) with
trypsin (2.5 g/l) and EDTA (l g/l) in phosphate-buffered saline,
pH 7.4. Less than l % of total glycosaminoglycan radioaetivity
remained in the well. Glycosaminoglycans were isolated from
the cell-free rnedium (after centrifugation for 6min, 1000g,
4 °C) and from the cells by exhaustive proteolysis in 0.1 mol/1
sodium acetate, pH 6.1, with papain (EC 3.4.22.2, Boehringer
GmbH, Mannheim, FRG) for 48 h at 60 °C (23, 34), followed
by batchwise (0.3 to 2.2 mol/1 NaCi) chromatography on
DEAE-Sephacel äs described (24). The efficiency of proteolytic
glycosaminoglycan extraction from cells and medium was more
than 90%. The radioaetivity of an aliquot of total labeled
giycosaminoglycans was determined, and radioaetivity was then
expressed on the basis of the cell number, DNA content, and
protein content of the cultures, respectively.
For analysis of specific types of glycosaminoglycan, total gly-
cosaminoglycans were subjected to consecutive degradations
with nitrous acid to obtain the incorporation of label into
heparan sulphate, and to enzymatic digestion with chondroitin
AC-(EC 4.2.2.5) and -ABC-lyases (EC 4.2.2.4) (Seikagaku Fine
Chemicals, Tokyo, Japan) to obtain the fractiöns of chondroitin
4,6-sulphate and dermatan sulphate, respectively. Analytical
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details of the procedure are reported elsewhere (23, 29, 34, 40).
Total degradation efficiency was determined by the degradation
of biosynlhetically labeled rat liver heparan sulphate and of in
vitro N-[3H]acetyl-labeled chondroitin sulphate and dermatan
sulphate (Sigma Chemical Company); the efficiency of degra-
dation was found to be betwcen 85 and 96% (23).
Determination of radioactively labeled hyaluronic
acid
Total [3H]glucosamine-labeled glycosaminoglycans were iso-
lated by batchwise DEAE-sephacel chromatography äs de-
scribed above but the resin was initially equilibrated with 0.1
mol/l sodium acetate, pH 6.2 before the absorbed material was
eluted with 2.2 raol/1 NaCl. The glycosaminoglycans in the
eluate were precipitated with 4 ml absolute ethanol for 12 h at
room tcmperature, then washed with absolute ethanol to re-
move NaCl and subjected to enzymatic digestion wilh hyalu-
ronate lyase (EC 4.2.2.1, from Streptomyes hyalurolyticus, Sei-
kagaku Co., Tokyo, Japan). Portions of 200 were incubatcd
for 3 h at 60 °C in 0.033 mol/l sodium acelate, pH 5.0 with 5
TRU hyaluronate lyase in a total reaction volumc of l ml.
Control incubations were performed with a similar volume of
0.1 mol/l NaCl instead of enzyme. After termination of the
reaction by cooling in ice those glycosaminoglycans not de-
graded by hyaluronate lyase were precipitated for 16h at room
temperature with 4 volumes of ethanol saturated with sodium
acetate, and centrifuged (4500g, 10 min). The Sediment was
dried, dissolved in water and counted for radioactivity. The
amount of labeled hyaluronic acid was calculated from the
diflerence between the control and enzyme incubations. The
analytical criteria of this method have been reported (37).
Determination of hyaluronic acid concentration in
the medium
Hyaluronate was measured with a radiometric assay (Phar-
macia Diagnostics AB, Uppsala, Sweden) based on principles
described in detail elsewhere (41). Briefly, a 125I-labeled cartilage
protein with specific affmity for hyahironate binds to hyalu-
ronic acid in the medium. The unbound fraction of the hyalu-
ronate binding protein is then quantitated by binding to hyalu-
ronate covalently coupled to sepharose. Thus, the radioactivity
bound to the particles is inversely proportional to the concen-
tration of hyaluronate in the medium. It was ascertained that
the test was specific for hyaluronic acid by showing that no
hyaluronate could be measured after digestion of the sample
with hyaluronate lyase äs described above. In each case the
hyaluronic acid concentration of the complete culture medium
before contact with fat-storing cells was determined (between
86.6 and 94.3 g/l) and subtracted from the concentration
measured after incubation with the cells.
General techniques
Cells were quantitated either by counting in a haemocytometer
or by fluorometric determination of DNA (42) using calf thy-
mus DNA (type I, Sigma Chem. Co., Munich, FRG) äs a
Standard. Protein was determined by the method of Lowry et
al. (43) using bovine senim albumin äs a calibrator. Cell viability
was determined with the trypan blue exclusion test.
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Fig. 1. Light microscopic appearance of hepatocytes (A), Kupf-
fer cells (B), and fat-storing cells (C) all on the 3rd day
of primary monolayer culture. Hepatocytes form tra-
beculae-like structures and often contain more than one
nucleus. Kupffer cells are spindle-shaped; fat-storing
cells are easily identified by numerous cytoplasmic fat
droplets arid Jong cellular extensions, which form a
network. Magnification 160x.
Results
General characterization of cuhured cells
The cells were cultured for up to 4 days äs monolayers,
during which time they expressed a typical morphol-
ogy (fig. 1). Hepatocytes formed trabeculae-like struc-
tures, and some cells contained more than one nu-
cleus. The mean viability of the cells on the 3rd day
of culture was 85%, and contaminating non-paren-
chymal cells were absent, äs determined by the meth-
ods described above. Fat-storing cells were character-
ized by abundant fat droplets (fig. 2) showing intense
(vitamin A) fluorescence upon Irradiation at 328 nm.
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Fig. 2. Electron micrograph of a fat-storing cell isolated from
rat liver. Multiple lipid (vitamin A-containing) droplets
(L). Bar = 2 μτη.
Comparison of total sulphated glycosami-
noglycan synthesis and secretion in hepato-
cytes and non-parenchymal cells
On the 3rd day of culture, each cell type was exposed
for 24 h under identical conditions to [35S]sulphate
and [3H]glucosamine, to deterinine the incorporation
of these precursors into the total glycosaminoglyoans
of cells and medium. Fat-storing cells showed the
highest rate of [35S]sulphate-labeled glycosaminogly-
can synthesis. When related to cell number, the
amount of labeled polysaccharide in hepatocytes was
about one third of that measured in fat-storing cells.
When related to the DNA- or to the protein^content,
the rate of incorporation of [35S]sulphate into glycps-
aminoglycans in hepatocytes was only 12% or 4%,
respectively, of that in fat-storing cells (fig. 3). Kupffer
cells contained only 4 to 8% of sulphated glycos-
aminoglycans when compared with fat-storing cells.
On the 3rd culture day they showed long cellular
extensions and a typical stellate shape. The cultures
were free of hepatocytes, and phagocytosing and per-
oxidase-positive cell contaminations were estimated
to be less than 5%. More than 85% of fat-storing
cells on the 3rd culture day excluded trypan blue.
Kupffer cells had a spindle-shaped cell body with
several protrusions; they all rapidly phagocytosed la-
tex beads, and their viability was about 90%. Hepa-
tocytes were absent from these cultures, whereas
traces (about 2%) of contaminating fat-storing cells
could not be avoided in a great number of cell iso-
lations. It was established that protein synthesis meas-
ured by incorporation of [3H]valine into total cellular
protein in cultures of all cell types preceded linearly
for at least 24 h (data not shown). Hepatocytes and
non-parenchymal cells showed different DNA- and
protein-contents and different protein/DNA ratios,
all parameters being higher in hepatocytes. In fat-
storing cells and Kupffer cells these parameters were
in the same order of magnitude (tab. 1).
Tab. 1. Protein and DNA Contents of freshly isolated fat-stor-
ing cells, hepatocytes, and Kupffer cells. Cells were
counted in a haemocytometer; DNA and protein were
determined in cell lysates prepared by sonifkation.
Mean values ± S. D. of 3 independent cell isolations
are shown.
Cell type DNA Protein Ratio
ceiis) (μg/106 cells) protein/
DNA
Fat-storing cells
Hepatocytes
Kupffer cells
10.5 + 3.1
25.9 + 1.6
6.8 ± 1.8
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Fig. 3. Incorporation of [3SS]sulphate into total glycosamino-
glycans of a) fat-storing cells, b) hepatocytes, and c)
Kupffer cells on the 3fd day of primary culture. After
labeling for 24 h with 0.37 MBq [35S]sulphate per 5 ml
raediurn, glycosaminoglycans of cells (€*) and medium
(Offl) were analysed separately. Rates of incorporation
are referred to cellular DNA, protein, and cell niimber,
respectively. Mean values ± S. D. of 4 independent ex-
β periments are shown.
J. Clin. Chem. Clin. Biochem. / Vol. 27,1989 / No. 3
Gressner and Schäfer: Glycosaminoglycan synthesis in various liver cell types 145
Thus, the proportional rates of sulphate incorporation
in fat-storing cells, hepatocytes, and Kupffer cells were
4:0.5:0.2 (referred to DNA content). Somewhat dif-
ferent proportions were obtained when
[3H]glucosamine was used äs an isotopic precursor
(tab. 2), but these data also demonstrate that fat-
storing cells are most active in the synthesis of labeled
glycosaminoglycans.
Tab. 2. Incorporation of [3H]glucosamine into total glycos-
aminoglycans of fat-storing cells, hepatocytes, and
Kupffer cells. The cells were incubated on the 3rd day
of primary culture with 0.37 MBq of [3H]glucosamine
per 5 ml medium. Glycosaminoglycans of cells and me-
dium were analysed separately. Rates of incorporation
are related to cellular DNA and protein, respectively.
Mean values ± S. D. of 4 experiments are listed.
Cell type [3H]glucosamine incorporation
(kBq/mg DNA · 24 h)
total cells medium
Fat-storing cells
Hepatocytes
Kupffer cells
47.5 + 2.0
27.0 -l· 2.0
3.8 + 0.3
10.0 ± 0.5
18.3 ± 2.3
1.8 ± 0.2
37.5 ± 1.6
8.7 ± 0.2
2.0 ± 0.3
(kBq/mg protein · 24 h)
total cells medium
Fat-storing cells
Hepatocytes
Kupffer cells
3.4 ± 0.22
0.6 ± 0.04
0.2 ± 0.03
0.7 ± 0.07
0.4 ± 0.05
0.1 ± 0.01
2.7 ± 0.22
0.2 ± 0.04
0.1 ± 0.02
The secretion rates of labeled glycosaminoglycans into
the medium were foutid to be strikingly different
between the various cell types (flg. 3, tab. 2). Most of
newly formed [35S]sulphate- or [3H]glucosamine-la-
beled polysaccharides in fat-storing cells were secreted
(fractions of 0.7 to 0.8) but in hepatocytes glycos-
aminoglycans remained predominantly celKassociated
(about 0.7). Nearly 0.8 of Kupffer cell-derived glycos-
aminoglycans were found in the cell layer.
Comparison of type-specific glycosamino-
glycan synthesis and secretion in hepatocytes
and non-parenchymal cells
The profile of [35S]sulphate-labeled glycosaminogly-
cans in fat-storing cells and Kupffer cells was signifi-
cantly different from that öf hepatocytes (fig. 4). In
parenchymal liver cells heparan sulphate contributed
about 90%, while chondroitm sulphate and dermatan
sulphate comprised less than 10% of total labeled
glycosaminoglycans. In the medium of hepatocyte
cultures, about 50% of nitrous acid labile material
(heparan sulphate) and about 35% chondroitin sul-
phate were found. In the medium of fat-storing cell
cultures, dermatan sulphate (DS) and chondroitin
sulphate (CS) were found to be the major fractions,
whereas heparan sulphate (HS) was the predominant
type in the cell layer (fig. 4). The pattern of sulphated
glycosaminoglycans in fat-storing cells (CS: DS: HS
= l: 0.6:1.7) resembled closely that of Kupffer cells
(CS:DS:HS = 1:0.7:1.4). In the medium of the
latter cell type the individual glycosaminoglycans were
present in nearly equal portions (fig. 4). A comparison
of incorporation rates of [35S]sulphate into specific
types of glycosaminoglycans of hepatocytes and fat-
storing cells showed that fat-storing cells secreted
nearly 11 times more labeled chondroitin sulphate
and even 900 times more dermatan sulphate into the
medium than the corresponding hepatocytes (tab. 3).
Fat-storing cells secreted a fraction of almost 0.8 of
labeled glycosaminoglycans into the medium, and he-
patocytes secreted 0.37 of newly formed polysacchar-
ides. In fat-storing cells, the fractional secretion rates
of chondroitin sulphate and dermatan sulphate
amounted 0.76, and that of heparan sulphate was
0.32.
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Fig. 4. Pattern of specific types of sulphated glycosaminogiy-
cans in cells (left) and medium (right) determined by
the fractional rates of incorporation of [35S]sulphate into
individual glycosaminoglycans of a) fat-storing cells, b)
hepatocytes, and c) Kupffer cells, respectively. Cells were
incubated with [35S]sulphate for 24h äs described in
fjgure 2. Glycosaminoglycans of cells and medium were
isolated and specified by enzymatic and chemical deg-
radation. The amount of a specific type is expressed
relative to that of total labeled glycosaminoglycans.
Mean values ± S. D. of 3 experiments are shown. H =
chondroitin sulphate; ^ = dermatan sulphate; M =
heparan sulphate.
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Tab. 3. Incorporation of [35S]sulphate into specific types of glycosaminoglycans of fat-storing cells and hepatocytes on the 3rd
day of culture. Cells were exposed for 24h to 0.74 MBq [35S]sulphate per 5 ml medium. Cells and medium were analysed
separately for individual types of labeled glycosaminoglycans. Mean values ± S. D. of 4 experiments are listed.
Cell type
Fat-storing cells
Hepatocytes
Kupffer cells
Glycosaminoglycan
Chondroitin sulphate
Dermatan suiphate
Heparan sulphate
Chondroitin sulphate
Dermatan sulphate
Heparan sulphate
Chondroitin sulphate
Dermatan sulphate
Heparan sulphate
[35S]sulphate incorporation
(kBq/mg DNA - 24 h)
cells
4.9 + 0.7
2.9 + 0.4
8.1 ± 1.2
0.3 ± 0.01
0.2 + 0.01
4.8 ±0.26
1.20 ±0.1 5
0.83 + 0.10
1.62 + 0.20
medium
17.3 ±4.0
26.0 ± 6.2
4.4 ± 1.0
1.5 ±0.07
0.03 ± 0.00
2.05 ± 0.10
0.29 ± 0.05
0.25 + 0.04
0.28 + 0.05
total
22.2 ±3.4
29.8 ±5.2
12.5 ±0.9
1.8 + 0.08
0.3 + 0.01
6.9 ± 0.53
1.55 ± 0.25
1.13 ± 0.16
1.96 ± 0.29
Ratio
medium/cells
3.5
9.2
0.5
6.2
0.1
0.4
0.2
-0.3
0.2
Comparison of hyaluronic acid synthesis and
secretion in hepatocytes and non-parenchy-
mal cells
The synthesis rate of [3H]ghicosamine-labeled glycos-
aminoglycans in the medium of fat-storing cells in-
creased with advancing culture time (flg. 5). A signif-
icant proportion of newly synthesized glycosamino-
glycans in the medium was identified s hyaluronic
acid. Its synthesis rate followed a time course similar
to that of total glycosaminoglycans. There was a
progressive decline of the fractional synthesis rate of
hyaluronic acid from an initial value of 0.7 down to
0.3 on the 8th day of culture. Complementary results
were obtained by measuring the chemical amount of
hyaluronic acid in the medium of fat-storing cells,
using a radiometric assay procedure. It is shown in
figure 6 that the amount of hyaluronic acid produced
daily in fat-storing cell cultures increased almost 5
fold between the 2nd and 6th culture day. When
related to the DNA content, fat-storing cells synthe-
sized on the 4th day 4.2 ± 0.8 μg hyaluronate per mg
DNA per hour (n = 4). More than 0.8 of the total
hyaluronate was found in the medium. The hyaluronic
acid concentration in the medium of Kupffer cell cul-
tures was much lower; the synthesis rate of hyaluron-
ate on the 3rd day of culture was calculated to be 1.3
+ 0.4 μg/mg DNA per hour (n = 4). In hepatocyte
cultures hyaluronate was not detectable with the ra-
diometric assay or by radioisotopic labeling.
Fig. 5. Culture time-dependent changes of the incorporation of
[3H]glucosamine into total glycosaminoglycans (a) and
hyaluronic acid (c) in the medium of fat-storing cells.
.The synthesis of labeled hyaluronate is expressed s a
fraction of total labeled glycosaminoglycans (b). The
inset in figure 5 b demonstrates the changes of DNA
per culture plate. Cells were seeded at a density of 0.25
• 106 cells/2 cm2. Mean values ± S. D. of 4 wells are
given.
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Fig. 6. Synthesis rate of hyaturonate in the medium of fat-
storing cells at various times of culture. Cells were
seeded at a density of 0.25 · l O6 cells/2cm2 well. The
medium was changed daily and used for determination
of the hyaluronate concentration. Mean values ± S. D.
of 5 wells are given.
Discussion
Of the 4 types of glycosaminoglycans, identified in
the extracellular matrix of the liver (25 — 27), 3 species
(heparan sulphate, chondroitin sulphate, dermatan
sulphate) are supposed to exist äs proteoglycans,
whose functions are only incompletely understood
(44, 45). These macromolecules consist of a core pro-
tein to which a number of unbranched, sulphated
(polyanionic) carbohydrate side chains (glycosami^
noglycans) are covalently attached (46). The proteo-
glycans can interact non-covalently with hyaluronic
acid, a large molecular weight, non-sulphated carbo-
hydrate chain devoid of a core proteiri (46, 47). He-
paran sulphate is the predominant type in liver (25 —
27,29). Its location is not restricted to the extracellular
matrix, and it is also found in high concentrations in
the pericellular coat (glycocalyx) of hepatoeytes (48,
49) and in intracellular compartments including the
nucleus (50, 51). The structure (52) and cellular origin
of heparan sulphate have been studied extensively.
Hepatoeytes were identified äs the main cellular
source of heparan sulphate (34, 53 — 55). In fact, in
early cultures of these cells heparan sulphate was
almost the only type of glycosaminoglycan produced
(55). In long-term cultures (> 4th/5th' day) hepato-
eytes were shown to produce increasing amounts of
other sulphated glycosaminoglycans, äs well äs hyalu-
ronic acid (56). The conclusions drawn from in vitro
studies on type-specific synthesis of connective tissue
molecules are critically dependent on the purity of the
cell culture. The problem of the contamination of
hepatocyte cultures by fat-storing cells has been
stressed in a recent study on Collagen synthesis of
hepatoeytes (57). Although, in the present study, we
also cannot definitely exclude the presence of a frac-
tion of contaminating fat-storing cells in the hepato-
cyte cultures, it is unlikely that the degree of contam-
ination is significant, because
(i) under the light microscope we did not observe
vitamin A-autofluorescence, or immunofluorescence
staining of desmin in fat-storing cells,
(ii) in the medium of hepatocyte cultures only trace
amounts of dermatan sulphate, the predominant type
in the medium of fat-storing cells, were found, and
(iii) hyaluronate, the major glycosaminoglycan in the
medium of fat-storing cells, was not detectable in
hepatocyte cultures.
We therefore consider that the fraction of condroitin
sulphate in the medium of hepatoeytes is a true syn-
thesis product of liver parenchymal cells. This result
confirms previous findings in short-term liver cell
Suspension cultures, in which a quantitatively similar
fraction of nitrous acid resistant glycosaminoglycans
was identified (58). The composition of proteoglycans
in the medium and cell fraction of fat-storing cells
resembled that described previously (23). Kupffer cells
contained almost equal amounts of all sulphated gly-
cosaminoglycan types in the cell and medium fraction,
respectively. Only fat-storing cells secrete most of their
newly synthesized proteoglycans into the extracellular
space.
For several reasons, the data on the incorporation
rates of radiolabeled isotopic precursors are difficult
to Interpret in terms of the synthesis rates of total
and specific types of sulphated proteoglycans:
(i) The rates of cellular uptake of [35S]sulphate and
pH]glucosamine and the respective precursor pool
sizes might be different between the three cell types.
The determination of the specific radioactivity of the
immediate precursors, i.e. UDP-N-acetyl glucos-
amine/-galactosamine (40) and 3'phosphoadenosine-
5'-phosphosulfate (PAPS) (59) was found to be diffi-
cult in the cell cultures and, hence, our data are not
corrected for this potential source of error.
(ii) The incorporation of [35S]sulphate measures pri-
marily the sulphation, a final step in the synthesis of
the carbohydrate chain, which implies that variations
in the degree of sulphation (over- and undersulpha-
tion) might result in over- or underestimation of the
respective synthesis rates. Oversulphated isomers of
dermatan sulphate containing disulphated disacchar-
ides are present in normal liver (26, 27). Therefore,
labeled glucosamine was used äs an alternative pre-
cursor for glycosaminoglycan synthesis.
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(iii) The proportion of the synthesis rates between the
cell types is dependent on the reference parameter
(cell number, DNA, protein).
(iv) As exemplified by hyahironate in the medium of
fat-storing cell cultures, the culture time is an impor-
tant determinant of the synthesis rate and even of the
composition of glycosaminoglycans.
As in other cell cultures, connective tissue synthesis
is turned on and qualitatively changed with advancing
culture time (8, 9, 12, 21, 56), due to phenotypic
adaptation of cells in culture. The loss of extracellular
matrix during cell Isolation is important in gene
expression, äs it may introduce different alterations
in gene regulation and abnormal gene expression in
the various cell types. We tried to standardize our
determination on the 3rd day of culture. The limita-
tions, which are inherent in most cell culture studies,
do not allow an extrapolation from the in vitro in-
corporation rates to in situ synthesis rates. Presently,
there are no techniques available allowing in situ
identification of the cellular sources and quantifica-
tion of the production rates of individual proteogly-
cans. According to our results, fat-storing cells are a
major source of connective tissue proteoglycans in
liver. These cells synthesize and secrete significant
amounts of a broad spectrum of those proteoglycans
(23) and hyaluronate (24) which are found in the
matrix of normal liver. The proteoglycans are bound
at least partially to hepatocellular surfaces (60) and,
thus, will infhience the microenvironment, intercellu-
lar communication and other cell surface functions of
the parenchymal cell. Since liver endothelial cells take
up and degrade hyaluronic acid (61, 62)> a fraction
ofthat glycosaminoglycan secreted by fat-storing cells
might follow this pathway. Presently, the functional
significance of sulphated proteoglycans and of hyalu-
ronic acid prodticed by fat-storirig cells is unknown.
In liver injury, proliferation and transformation of
fat-storing cells (63) might be the main mechanism of
local amplification of proteoglycan and hyaluronate
synthesis. Interestingly, mitotic activity (39, 64) and
the production rates of total glycosaminoglycans (65)
and of hyaluronate (66) in fat-storing cells in vitro
are significantly stimulated by secretions of activated
Kupffer cells. This observation indicates metabolic
cooperativity between the various cell types in the
formation of the hepatic extracellular matrix. Neither
Kupffer cells nor hepatocytes have beeh shown so far
to contribute directly to proteoglycan accumulation
during fibrogenesis. The results of this cömparative
study stress the potential importance of fat-storing
cells in the metabolism of glycosaminoglycans in the
extracellular matrix under normal and pathological
conditions.
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